These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3492281)

  • 1. Lymphocyte activation by oxidative modification: avidin-modified T cells activate biotin-modified autologous T cells but not vice versa.
    Roffman E; Wilchek M
    Cell Immunol; 1986 Nov; 103(1):140-6. PubMed ID: 3492281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane sialoglycolipids emerging as possible signal transducers for lymphocyte stimulation.
    Spiegel S; Wilchek M
    J Immunol; 1981 Aug; 127(2):572-5. PubMed ID: 6972969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extent of oxidative mitogenesis does not correlate with the degree of aldehyde formation of the T lymphocyte membrane.
    Roffman E; Wilchek M
    J Immunol; 1986 Jul; 137(1):40-4. PubMed ID: 3086457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocytin hydrazide--a selective label for sialic acids, galactose, and other sugars in glycoconjugates using avidin-biotin technology.
    Bayer EA; Ben-Hur H; Wilchek M
    Anal Biochem; 1988 May; 170(2):271-81. PubMed ID: 2456025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective covalent modification of newly synthesized activation-induced sialoglycoconjugates on the T lymphocyte membrane.
    Roffman E; Wilchek M
    Biochem Biophys Res Commun; 1986 Mar; 135(2):473-9. PubMed ID: 3008722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-based detection of glycoproteins on blot transfers using avidin-biotin technology.
    Bayer EA; Ben-Hur H; Wilchek M
    Anal Biochem; 1987 Feb; 161(1):123-31. PubMed ID: 3034095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface engineering of living myoblasts via selective periodate oxidation.
    De Bank PA; Kellam B; Kendall DA; Shakesheff KM
    Biotechnol Bioeng; 2003 Mar; 81(7):800-8. PubMed ID: 12557313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the structure of processed antigen by using biotin and avidin. MHC-dependent inhibition of responses to selected biotinyl-insulin derivatives.
    Jensen PE; Wilkinson KD
    J Immunol; 1989 Dec; 143(11):3423-9. PubMed ID: 2685118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of ferritin-avidin conjugates by reductive alkylation for use in electron microscopic cytochemistry.
    Bayer EA; Skutelsky E; Wynne D; Wilchek M
    J Histochem Cytochem; 1976 Aug; 24(8):933-9. PubMed ID: 182877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte enumeration: a comparison between a modified avidin-biotin-immunoperoxidase system and flow cytometry.
    Paradis IL; Merrall EJ; Krell JM; Dauber JH; Rogers RM; Rabin BS
    J Histochem Cytochem; 1984 Apr; 32(4):358-62. PubMed ID: 6368677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grafting of triggering sites onto lymphocytes: requirement of multivalency in the stimulation of dinitrophenyl-modified thymocytes by anti-dinitrophenyl antibody.
    Ravid A; Novogrodsky A; Wilchek M
    Eur J Immunol; 1978 May; 8(5):289-94. PubMed ID: 308451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the avidin-biotin complex for specific staining of biological membranes in electron microscopy.
    Heitzmann H; Richards FM
    Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3537-41. PubMed ID: 4139715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of N-bromosuccinimide on the sub-unit structure of acidin and its complexes with biotin.
    Green NM; Ross ME
    Biochem J; 1968 Nov; 110(1):59-66. PubMed ID: 5722693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of the 2-iminobiotin-avidin interaction for the selective retrieval of labeled plasma membrane components.
    Orr GA
    J Biol Chem; 1981 Jan; 256(2):761-6. PubMed ID: 6161128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective elimination of a B cell subset having acceptor site(s) for T cell-replacing factor (TRF) with biotinylated antibody to the acceptor site(s) and avidin-ricin A-chain conjugate.
    Hashimoto N; Takatsu K; Masuho Y; Kishida K; Hara T; Hamaoka T
    J Immunol; 1984 Jan; 132(1):129-35. PubMed ID: 6418795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversibility of biotin-binding by selective modification of tyrosine in avidin.
    Morag E; Bayer EA; Wilchek M
    Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):193-9. PubMed ID: 8645205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CD2 cross-linking in cytoplasmic calcium responses and T cell activation.
    Ledbetter JA; Rabinovitch PS; Hellström I; Hellström KE; Grosmaire LS; June CH
    Eur J Immunol; 1988 Oct; 18(10):1601-8. PubMed ID: 2461308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of T cells by cross-linking an anti-CD3 antibody with a second anti-T cell antibody: mechanism and subset-specific activation.
    Walker C; Bettens F; Pichler WJ
    Eur J Immunol; 1987 Jun; 17(6):873-80. PubMed ID: 2439351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sodium periodate modification of lymphocytes on the sensitization and lytic phases of T cell-mediated lympholysis.
    Schmitt-Verhulst A; Shearer GM
    J Immunol; 1976 Apr; 116(4):947-58. PubMed ID: 56407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of lymphocyte surface properties by insertion of foreign functional components of plasma membrane.
    Prujansky-Jakobovits A; Volsky DJ; Loyter A; Sharon N
    Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7247-51. PubMed ID: 6261248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.